PHARMAPLUS ROCOURT
ActiveDirectors
Directors
3 directors, last change in 2026
Board 3
GFB MANAGEMENT
Current
Director (not named in the articles) · appointed in the act of 08-09-2026 · Private limited company · permanent representative: Roel Fiey
PHARMA INVEST MANAGEMENT
Current
Director (not named in the articles) · in office according to the act of 19-12-2023 · earlier manager, until 19-12-2023 · earlier director, until 01-04-2026 · term without a fixed end · Private limited company · permanent representative: PIRENNE Hubert · also on the board of 2 other companies
VSF MANAGEMENT SRL
Current
Director · appointed in the act of 22-05-2026 · earlier director (not named in the articles), until 08-09-2026 · Legal entity · permanent representative: Fiey Roel
Permanent representatives 2
Roel Fiey
Current
Permanent representative · appointed in the act of 08-09-2026 · for GFB MANAGEMENT
PIRENNE Hubert
Current
Permanent representative · in office according to the act of 19-12-2023 · for PHARMA INVEST MANAGEMENT
Owners and capital
Shareholders
1 ownerChain of control
- PHARMA INVEST MANAGEMENT
- PHARMAPLUS ROCOURT
Owners 1
- PHARMA INVEST MANAGEMENTparentEquity €821,234 Profit of €35,265 in 2025 (profit of €44,663 in 2024) Checked score 9198%
Capital transactions
Capital over time
- 19-12-2023 Converted to unavailable equity
Mandate history
3 people, 3 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| PHARMA INVEST MANAGEMENT |
|
| VSF MANAGEMENT SRL |
|
| GFB MANAGEMENT |
|
Articles of association
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Un mois, commun accord ou défaut Président du Tribunal de l'Entreprise du siège”
Articles of association, deed of 19-12-2023 (in French)